Risk of cardiovascular disease among different fluoropyrimidine-based chemotherapy regimens as adjuvant treatment for resected colorectal cancer

BACKGROUND: Patients with colorectal cancer (CRC) are more likely to develop cardiovascular disease (CVD) than those without cancer. Little is known regarding their CV risk after operative chemotherapy. We aimed to compare the risk of CV disease among different fluoropyrimidine derivatives. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wen-Kuan, Ho, Wei-Pang, Hsu, Hung-Chih, Chang, Shu-Hao, Chen, Dong-Yi, Chou, Wen-Chi, Chang, Pei-Hung, Chen, Jen-Shi, Yang, Tsai-Sheng, See, Lai-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381971/
https://www.ncbi.nlm.nih.gov/pubmed/35990963
http://dx.doi.org/10.3389/fcvm.2022.880956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381971/
https://www.ncbi.nlm.nih.gov/pubmed/35990963
http://dx.doi.org/10.3389/fcvm.2022.880956

Ejemplares similares